According to the Legislative Budget Board (LBB), HB 4882 would have a negative fiscal impact of $435,790 to General Revenue during the 2026–27 biennium. Although the bill does not itself appropriate funds, it would provide the statutory authority for future appropriations to implement its provisions. The estimated ongoing cost to the state would continue beyond the biennium, with annual General Revenue costs of approximately $241,000 per year beginning in fiscal year 2028.

The projected costs are primarily attributable to the Department of State Health Services (DSHS), which estimates it would require 2.0 additional full-time equivalent employees to administer the expanded congenital cytomegalovirus (CMV) testing program. These positions would support newborn screening follow-up activities, maintain and analyze CMV testing data, provide technical assistance to screening providers, and perform administrative oversight of the new testing requirements. Personnel-related expenses account for nearly all of the estimated fiscal impact.

The Health and Human Services Commission reported that any costs to the agency associated with the bill could be absorbed within existing resources. Additionally, the LBB determined that no significant fiscal impact on local governments is anticipated, indicating that implementation costs would primarily be borne at the state level through DSHS.

HB 4882 expands the scope of Texas' newborn screening program by requiring routine congenital cytomegalovirus (CMV) testing for newborns before discharge from certified birthing facilities, unless a parent declines or another statutory exception applies. The committee analysis emphasizes that congenital CMV is a leading cause of non-genetic childhood hearing loss and that early testing may improve opportunities for intervention before hearing loss or developmental disabilities become apparent.

From a limited-government perspective, the bill does increase the size and scope of government, though in a targeted manner. It expands the responsibilities of the Department of State Health Services by adding a statewide testing and data collection function to an existing newborn screening program and requires the agency to administer and monitor the expanded program. The LBB estimates this expansion will require two additional full-time state employees and result in a General Revenue cost of approximately $435,790 during the 2026–27 biennium, with recurring annual costs thereafter. While the Health and Human Services Commission expects to absorb its implementation costs within existing resources, the bill nevertheless increases state administrative responsibilities and taxpayer-supported expenditures.

The bill imposes only a modest additional regulatory burden. Certified birthing facilities would be required to incorporate CMV testing into their discharge procedures and comply with associated reporting requirements, but these obligations are integrated into an existing newborn hearing screening framework rather than creating a new standalone regulatory program. Importantly, the legislation does not create any criminal penalties, grant new rulemaking authority, or establish significant new compliance requirements for private individuals beyond the testing process itself. Parents retain the explicit right to decline testing, preserving an element of individual choice.

Overall, the bill presents a policy tradeoff. It modestly expands government responsibilities, increases state expenditures, and adds incremental regulatory requirements for healthcare providers, but it does so in pursuit of earlier identification of a condition associated with lifelong hearing and developmental disabilities. The expansion is relatively limited in scope, leverages an existing newborn screening infrastructure, preserves parental opt-out rights, and is projected to have no significant fiscal impact on local governments. As such, Texas Policy Research recommends that lawmakers vote YES on HB 4882.

• Individual Liberty: The bill modestly impacts individual liberty by making congenital cytomegalovirus (CMV) testing the default standard of care for newborns before discharge. However, this impact is substantially mitigated because parents retain the explicit right to decline both the hearing screening and CMV test. The legislation does not impose criminal penalties or otherwise compel participation beyond establishing a default testing requirement.
• Personal Responsibility: The bill neither significantly strengthens nor weakens personal responsibility. While it expands the state's role in facilitating newborn screening, parents retain decision-making authority through the opt-out provision. The legislation does not create new public benefits or shift responsibility for child health decisions away from families, instead providing parents with additional information and the opportunity to make an informed choice.
• Free Enterprise: The bill imposes a modest additional regulatory obligation on certified birthing facilities by requiring CMV testing and associated reporting before discharge. However, because these requirements are incorporated into an existing newborn screening program and apply uniformly to participating facilities, they do not substantially alter market competition or create significant barriers to entry. The measure does not regulate prices, restrict competition, or provide subsidies to favored entities.
• Private Property Rights: The bill has no meaningful effect on private property rights. It does not authorize takings, restrict the use or disposition of private property, create land-use regulations, or impose new obligations tied to real or personal property ownership.
• Limited Government: The bill expands the responsibilities of state government by requiring universal CMV testing through the existing newborn screening program, directing the Department of State Health Services to collect and maintain additional data, and increasing ongoing administrative responsibilities. According to the LBB, implementation requires two additional state employees and approximately $435,790 in General Revenue during the 2026–27 biennium, with recurring annual costs thereafter. Although the expansion is relatively limited and builds upon an existing program rather than creating a new agency, it nevertheless increases the size, scope, and cost of state government.